|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.66 USD | -2.99% |
|
-8.59% | -30.71% |
| 07-17 | EyePoint Pharmaceuticals Agrees to Settle US False Claims Act Allegations | MT |
| 07-16 | Stifel Initiates EyePoint Pharmaceuticals at Buy With $40 Price Target | MT |
| Market Cap | 1.06B 930M 863M 793M 1.49B 102B 1.52B 10.29B 4.03B 50.12B 3.98B 3.9B 173B | P/E 2026 * |
-3.55x | P/E 2027 * | -4.26x |
|---|---|---|---|---|---|
| Enterprise Value | 767M 672M 624M 573M 1.08B 74.02B 1.1B 7.43B 2.91B 36.22B 2.88B 2.82B 125B | EV / Sales 2026 * |
438x | EV / Sales 2027 * | 27.4x |
| Free-Float |
96.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: EyePoint, Inc.
| 1 day | -2.99% | ||
| 1 week | -8.59% | ||
| Current month | -11.47% | ||
| 1 month | -7.79% | ||
| 3 months | -11.10% | ||
| 6 months | -22.50% | ||
| Current year | -30.71% |
| 1 week | 12.45 |  | 13.79 |
| 1 month | 12.45 | | 15.92 |
| Current year | 11.3 | | 18.87 |
| 1 year | 9.4 | | 19.11 |
| 3 years | 3.91 | | 30.99 |
| 5 years | 2.19 | | 30.99 |
| 10 years | 2.19 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 67 | 2023-07-09 |
George Elston
DFI | Director of Finance/CFO | 61 | 2019-11-13 |
Ramiro Ribeiro
CTO | Chief Tech/Sci/R&D Officer | 43 | 2024-03-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Jay Duker
BRD | Director/Board Member | 67 | 2023-07-09 |
| Chairman | 77 | 2018-09-09 | |
John Landis
BRD | Director/Board Member | 73 | 2018-10-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/10/26 | Fiscal year | Chief Executive Officer | 41,393 | 0.0494% | ||
| 6/30/26 | Fiscal year | Chief Technology Officer | 14,625 | 0.0174% | ||
| 5/25/26 | Fiscal year | Chief Financial Officer | 18,627 | 0.0222% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.99% | -8.59% | +21.15% | +10.96% | 1.09B | |
| -1.05% | +0.55% | +49.79% | +151.71% | 1,048B | |
| +2.00% | +3.49% | +52.22% | +50.20% | 603B | |
| -1.09% | +3.76% | +35.37% | +76.22% | 452B | |
| -0.42% | +1.65% | +30.05% | +21.05% | 327B | |
| -0.16% | +2.39% | +36.91% | +37.33% | 283B | |
| +1.68% | +2.73% | +24.14% | +17.94% | 259B | |
| -1.40% | -0.06% | -22.24% | -42.39% | 219B | |
| -0.05% | +2.16% | +19.75% | +55.89% | 198B | |
| +0.05% | -1.03% | +18.31% | +61.63% | 162B | |
| Average | -0.55% | +1.07% | +26.54% | +44.05% | 355.28B | |
| Weighted average by Cap. | -0.47% | +1.69% | +36.10% | +72.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.75M 1.53M 1.42M 1.31M 2.47M 169M 2.5M 16.97M 6.64M 82.71M 6.58M 6.43M 286M | 32.76M 28.7M 26.65M 24.48M 46.14M 3.16B 46.82M 317M 124M 1.55B 123M 120M 5.34B |
| Net income | -316M -277M -257M -236M -445M -30.51B -452M -3.06B -1.2B -14.93B -1.19B -1.16B -51.57B | -289M -253M -235M -216M -407M -27.9B -413M -2.8B -1.1B -13.65B -1.09B -1.06B -47.16B |
| Net Debt | -294M -258M -239M -220M -415M -28.4B -421M -2.85B -1.12B -13.9B -1.1B -1.08B -48.01B | -164M -143M -133M -122M -230M -15.79B -234M -1.59B -621M -7.72B -614M -601M -26.69B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-22 | US$12.66 | -2.99% | 1,063,986 |
| 26-07-21 | US$13.05 | +3.08% | 1,585,308 |
| 26-07-20 | US$12.66 | -4.81% | 1,099,731 |
| 26-07-17 | US$13.30 | +1.99% | 1,283,890 |
| 26-07-16 | US$13.04 | -5.85% | 1,551,216 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EYPT Stock
Select your edition
All financial news and data tailored to specific country editions
